22 results
8-K
EX-99.1
SANA
Sana Biotechnology Inc
1 Jun 22
Sana Biotechnology Announces Plan to Relocate Manufacturing to Bothell, Washington Along with Key Executive Hires in Manufacturing and Regulatory
4:14pm
and Regulatory
Replacement of Fremont, CA Facility Estimated to Save Over $100M in the Next Three Years
Global Cell Therapy Manufacturing Expert Snehal
DEF 14A
SANA
Sana Biotechnology Inc
26 Apr 22
Definitive proxy
6:08am
Maltzahn, Ph.D.º
Mary Agnes (Maggie) Wilderotter**
X§
X*
Patrick Y. Yang, Ph.D.
Total committee meetings in 2021
Current chairperson
Financial Expert … expert,” as such term is defined in Item 407(d)(5) of Regulation S-K. In making this determination, our Board considered each of Mses. Seitz
S-1/A
EX-10.2
pl3gu
28 Jan 21
IPO registration (amended)
7:56am
CORRESP
7saa78wphcjcnyx
20 Jan 21
Correspondence with SEC
12:00am
S-1
EX-10.17
nbzxwbpxifs
13 Jan 21
IPO registration
12:00am
S-1
EX-10.18
i6xf25h
13 Jan 21
IPO registration
12:00am
S-1
EX-10.20
vyyz t7ew61b
13 Jan 21
IPO registration
12:00am
S-1
EX-2.1
dleg7al cwkd
13 Jan 21
IPO registration
12:00am
S-1
EX-2.2
hd0jk15v4y8qd0j kjm
13 Jan 21
IPO registration
12:00am
S-1
EX-10.15
kxsw3iof yd4z
13 Jan 21
IPO registration
12:00am
S-1
EX-3.3
5y557lc3gp5esfi83rx
13 Jan 21
IPO registration
12:00am
S-1
EX-2.3
gy111k dzrp
13 Jan 21
IPO registration
12:00am
DRS/A
EX-2.3
q1tteri4gadi28jth4r
18 Dec 20
Draft registration statement (amended)
12:00am
DRS/A
EX-2.2
05rltpm6nu
18 Dec 20
Draft registration statement (amended)
12:00am
DRS/A
EX-2.1
glpyzeexurof
18 Dec 20
Draft registration statement (amended)
12:00am
DRS/A
EX-3.3
6bs8rkv079de593mm2
18 Dec 20
Draft registration statement (amended)
12:00am